Skip to content

A Clinical Efficacy Study of Qingyu Wenshen Granules on IVF-ET in Patients with Endometriosis Induced Infertility of Kidney Deficiency and Blood Stasis Type.

A Clinical Efficacy Study of Qingyu Wenshen Granules on IVF-ET in Patients with Endometriosis Induced Infertility of Kidney Deficiency and Blood Stasis Type.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000371
Enrollment
Unknown
Registered
2026-02-13
Start date
2025-10-19
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

Experimental group:Qingyu Wenshen Granules + Long-term ovulation induction IVF-ET treatment
Control group:Long-term ovulation induction IVF-ET treatment

Sponsors

Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of Western medicine for endometriosis; 2 Meet the diagnostic criteria of traditional Chinese medicine for kidney deficiency and blood stasis syndrome; 3 Meet the diagnostic criteria for infertility; 4 Age =25 years and =45 years old; 5 The menstrual cycle is regular and fluctuates between 21-35 days, and the menstrual period fluctuates between 3-7 days; 6 Women with reproductive needs; 7 Have not undergone any surgery within 3 months before participating in this study; 8. Have never undergone in vitro fertilization-frozen embryo transfer in the past; 9. Exclude male factor infertility; 10 Understand, agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Endocrine diseases, cardiovascular diseases, dyslipidemia, systemic lupus erythematosus or others Self-existing chronic ovulation disorders such as polycystic ovary syndrome, adenomyosis, and autoimmune diseases disease, human immunodeficiency virus infection, or any active infection; 2. Fallopian tube ligation and resection due to other diseases, abnormal development of the reproductive system, and infectious diseases Factors such as intrauterine adhesions and uterine malformations causing infertility; 3. Have a smoking habit (smoking in the past five years, =5 cigarettes a day); 4. Use of hormonal drugs or hormonal/non-hormonal anti-inflammatory drugs within 3 months before treatment; 5. In pregnancy.

Design outcomes

Primary

MeasureTime frame
High quality embryo rate;

Secondary

MeasureTime frame
cumulative clinical pregnancy rate;TCM Syndrome scoring form;Egg retrieval rate;Mature egg rate;Follicular fluid TNF-a content;Follicular fluid AKT1 content;Follicular fluid IL-6 content;Follicular fluid p53 content;Fertilized egg cleavage rate;

Countries

China

Contacts

Public ContactYang Cao

Shanghai University of Traditional Chinese Medicine

cindy8813966@126.com+86 137 6429 3960

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026